CINtec® PLUS Cytology offered as a reflex test when cytology is NILM and HPV positive ELMWOOD PARK, NJ, 9 de febrero de 2023 – BioReference® Health LLC, one of the largest full-service specialty laboratories in the United States, announced today it will be one of the first commercial laboratories to use offer the CINtec® PLUS Cytology test from […]
Archivos del autor: katie carrera
09
Feb.
Feb.
Cervical cancer is one of the most preventable forms of cancer. However, each year in the United States, an estimated 13,000 new cases of cervical cancer are diagnosed and 4,000 women die of this cancer, according to the Centers for Disease Control and Prevention. Screening tests and the HPV vaccine are the keys to prevention. When cervical cancer […]
17
Nov
Nov
You might have noticed an update in our name from BioReference Laboratories, Inc. to BioReference Health, LLC. While it may be a small shift in what we call ourselves, our new identity represents a significant difference in how we deliver our solutions and services. For more than four decades, BioReference has built a legacy based […]
16
Nov
Nov
It’s not just flu season. It’s the flu, COVID-19, and RSV (respiratory syncytial virus) season. While the flu has been diminished for the past two years due to the COVID-19 pandemic safety measures, such as people staying home and wide-spread masking, experts suggest that this could lead to reduced population immunity.1 These factors can bring […]
LabPulse.com Aspira Women’s Health on Wednesday announced a collaboration for ovarian cancer testing with Opko Health’s BioReference Laboratories. The firms will co-market and distribute Aspira’s Ova1Plus, which combines its U.S. Food and Drug Administration-cleared blood tests, Ova1 and Overa, to detect the risk of ovarian malignancy in women with adnexal masses prior to surgery. Under the […]
Comunicado de prensa
Aspira Women’s Health Announces Formal Launch of Co-Marketing and Distribution Collaboration with BioReference
05
Oct.
Oct.
Aspira Women’s Health Inc. OVA1Plus® now available to an expanded network of physicians, supporting patients nationwide AUSTIN, Texas, 5 oct 2022 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced the formal launch of its co-marketing and distribution collaboration with BioReference®, an OPKO Health […]
26
Ago.
Ago.
El Día de la Igualdad de la Mujer se celebra todos los años el 26 de agosto para conmemorar la aprobación del derecho a voto de las mujeres en los Estados Unidos, un hito histórico para los desafíos que tuvieron que enfrentar las mujeres para impulsar su movimiento de liberación. LA HISTORIA El movimiento feminista surgió a principios del siglo XIX, en un momento en el que las mujeres estadounidenses no podían heredar propiedades ni ganar […]
25
Ago.
Ago.
La atrofia muscular espinal (AME) afecta a 1 de cada 8,000 a 10,000 personas en el mundo, según la Biblioteca Nacional de Medicina de los Estados Unidos.1 Durante el mes de concientización sobre la AME, queremos dirigir la atención a este trastorno genético resaltando información sobre cómo se hereda la enfermedad y las opciones de pruebas para detectarla durante el embarazo y antes de la concepción. ¿Qué es la AME? Atrofia […]
23
Ago.
Ago.
Si se está preparando para volver al campus o está enviando a un estudiante, el inicio de un nuevo semestre es el momento perfecto para fomentar la educación en salud sexual. Estar informado sobre el mayor riesgo de infecciones de transmisión sexual que pueden enfrentar los estudiantes universitarios es un factor importante al momento de brindar asistencia en salud sexual y general […]
Comunicado de prensa de OPKO, MIAMI, 16 ago 2022 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK), una compañía biofarmacéutica y de diagnóstico multinacional, anunció hoy que Jon R. Cohen, M.D., deja su puesto de presidente y director ejecutivo de BioReference Laboratories y vicepresidente sénior y director de OPKO. Sin embargo, continuará como […]
